Bayer: Parkinson Disease trials
The registry lists 12 Parkinson Disease studies with Bayer as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 5Phase 3 1No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)Not yet recruitingNCT07566429Phase 2
- A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's MedicationsRecruitingNCT07330258
- Open-Label, Multi-Stage Study to Optimize the Intraputaminal Administration of AB-1005 Using a Prescriptive Infusion Algorithm (PIA)Not yet recruitingNCT07215403Phase 2
- AB-1005 Long-Term Follow-up StudyEnrolling by invitationNCT07081841
- A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseaseRecruitingNCT06944522Phase 3
- Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01Enrolling by invitationNCT05897957
- A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Active, not recruitingNCT06285643Phase 2
- Pre-Gene Therapy Study in Parkinson's Disease and Multiple System AtrophyCompletedNCT05699460
- Noninterventional Study Evaluating Parkinson's Disease Diary UseActive, not recruitingNCT05363046
- Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's DiseaseCompletedNCT04802733Phase 1
- Pilot Study of Safety and Efficacy of SpheramineTerminatedNCT00761436Phase 2
- STEPS Trial - Spheramine Safety and Efficacy StudyTerminatedNCT00206687Phase 2